Real-time assessment of corneal endothelial cell damage following graft preparation and donor insertion for DMEK.

In-situ graft viability assessment using clinical imaging devices provides comparable information to ex-vivo methods. This method shows high sensitivity and specificity, is non-toxic and can be used to evaluate immediate cell viability in new grafting techniques in-vivo.